S113G (p.Ser113Gly) variant of CASQ2 (Calsequestrin-2)

S113G (p.Ser113Gly) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Cardiovascular phenotype. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes structural context.

S113G (p.Ser113Gly) variant details